New computational method for drug discovery

July 12, 2018, Heidelberg Institute for Theoretical Studies
The cover image illustrates the TauRAMD method which is based on the Random Acceleration Molecular Dynamics technique and designed for computation of the relative residence times, tau, of drug-like compounds. Credit: Daria Kokh

HITS researchers developed tauRAMD, a tool to predict drug-target residence times from short simulations. The method is illustrated on the cover page of July 2018 issue of the Journal of Chemical Theory and Computation, software is freely available.

The design of a with a desired duration of action, whether long or short, is usually a complicated and expensive trial-and-error process guided only by a mix of expert intuition and serendipity. One of the parameters affecting drug efficacy is the lifetime of the complex formed between a drug and its , whose function must be altered, e.g. inhibited. In practice, many possible chemical compounds have to be synthesized and then tested to discover an appropriate drug candidate.

Easy method and high performance

As a part of the Kinetics for Drug Discovery (K4DD) project supported by the EU/EFPIA Innovative Medicines Initiative Joint Undertaking, researchers at the Molecular and Cellular Modeling (MCM) group at the Heidelberg Institute for Theoretical Studies (HITS) developed a computationally efficient and easy-to-use method for predicting the relative lifetimes of complexes of a target protein with different drug candidates. The scientists demonstrated the high predictive performance of the computational approach using experimental data measured by collaborators at Merck KGaA (Darmstadt), Sanofi-Aventis Deutschland (Frankfurt am Main), and Sanofi R&D (Vitry-sur-Seine, France).

The , called tauRAMD (residence time, tau, estimation using Random Acceleration Molecular Dynamics simulations) has been developed for ease of use and makes it possible to compute long residence times with short simulations. It has been successfully applied to diverse sets of compounds binding a range of therapeutically important target proteins. The software is freely available at https://www.h-its.org/downloads/ramd/.

Explore further: A matter of mobility: multidisciplinary paper suggests new strategy for drug discovery

More information: Daria B. Kokh et al. Estimation of Drug-Target Residence Times by τ-Random Acceleration Molecular Dynamics Simulations, Journal of Chemical Theory and Computation (2018). DOI: 10.1021/acs.jctc.8b00230

Related Stories

A lipid 'trap' inside cells reduces drug effectiveness

May 18, 2018

Cellular lipids are more efficient than proteins in trapping most drugs and hence reducing the free intracellular drug concentration. This is shown by researchers at Uppsala University in an article published in Molecular ...

Recommended for you

New battery gobbles up carbon dioxide

September 21, 2018

A new type of battery developed by researchers at MIT could be made partly from carbon dioxide captured from power plants. Rather than attempting to convert carbon dioxide to specialized chemicals using metal catalysts, which ...

Scientists solve the golden puzzle of calaverite

September 21, 2018

Scientists from Russia and Germany have shed light on the crystalline structure of calaverite, foretelling the existence of a new gold compound previously unknown to chemists. The results of their study were published in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.